PEG-3350 and Electrolytes (Kremers Urban Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the PEG-3350 and Electrolytes drug offered from Kremers Urban Pharmaceuticals Inc.. This Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Kremers Urban Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE, and SODIUM SULFATE |
| SUBSTANCE NAME: | POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 1984-10-26 |
| END MARKETING DATE: | 0000-00-00 |
PEG-3350 and Electrolytes HUMAN PRESCRIPTION DRUG Details:
| Item Description | PEG-3350 and Electrolytes from Kremers Urban Pharmaceuticals Inc. |
| LABELER NAME: | Kremers Urban Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 240; 5.84; 2.98; 6.72; 22.72(g/4L; g/4L; g/4L; g/4L; g/4L) |
| START MARKETING DATE: | 1984-10-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62175-446_cd812ad9-6f77-4c30-b736-97ada7e29063 |
| PRODUCT NDC: | 62175-446 |
| APPLICATION NUMBER: | NDA018983 |
Other POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM SULFATE Pharmaceutical Manufacturers / Labelers:
